VGM Group joins as Owlet's inaugural Owlet for Orgs program partner. Katie Morris Updated 2:52 PM CDT, Wed May 20, 2026 In March, Owlet, Inc., the pioneer of smart infant monitoring, announced the launch of Owlet for Orgs, a new employer benefit program that enables companies to provide new and expecting parents with its trusted infant health technology. Owlet announced VGM Group, as their inaugural employer partner. Through Owlet for Orgs, employers can provide new and expecting parents with FDA-cleared Dream Sock(R) or Dream Duo(TM) 3, which includes Dream Sock and all-new Dream Sight(TM) video monitor, as part of a customized workplace benefits package. By doing so, forward-thinking employers can support new parents through one of life's most important transitions - building a healthier team in the process by encouraging better sleep and focus and driving stronger loyalty and retention. Owlet works directly with HR and benefits teams to ensure the program is tailored to the organization and the rollout is seamless. "Early parenthood is one of the most overwhelming seasons of a person's life, and the businesses that acknowledge that are building stronger, more loyal teams," said Jonathan Harris, Chief Executive Officer at Owlet. "Owlet for Orgs gives companies a way to show up for their employees when it matters most, with more than just a policy on paper. We're proud to launch this program, and we look to expand our partners for this program in the months ahead." VGM Group is a 100% employee-owned company with a track record of supporting working parents. In 2023, it opened an on-site child care center at its headquarters in Waterloo, Iowa, in response to employee owners' challenges finding reliable, affordable child care. This focus on supporting working parents and community well-being aligns with Owlet's mission of preventive pediatric care. And it has earned VGM Group recognitions as an Iowa Top Workplace and a Best Place for Working Parents. "At VGM Group, caring for our employee owners means caring for the people who matter most to them," said Sara Laures, VGM Group Chief People Officer. "Along with benefits like our on-site child care center and free health clinic, Owlet for Orgs is another way we're investing in our people during one of life's most meaningful times. When new parents feel supported and confident in their baby's well-being, it creates peace of mind at home and allows them to stay engaged at work." The launch of Owlet for Orgs advances Owlet's mission to give families everywhere clarity, confidence, and peace of mind from night one. The program expands access to Owlet's growing ecosystem of clinical-grade products, among them the first and only FDA-cleared baby monitor on the market, Dream Sock, and insurance-supported prescription BabySat(R). Via its advocacy arm, Owlet Cares, the company works with 40+ nonprofit organizations across the globe to provide products, resources, and safe sleep education to even more families. Owlet for Orgs is the next natural step, extending that same ecosystem of care beyond the home and into the broader network of professionals and organizations that families trust. About VGM Group Headquartered in Waterloo, Iowa, VGM is a 100% employee-owned company providing business and professional services to thousands of business customers across North America. Services include group purchasing, commercial insurance, management of healthcare services and networks in post-acute cases, healthcare distribution direct to patient homes, specialty consulting, and online education, as well as digital, print, and traditional marketing and more. VGM employs approximately 1,600 people across 42 states and Canada, with more than 1,100 working in Iowa. VGM has been named the Top Workplace in Iowa, Employer of Choice, and Best Place for Working Parents on multiple occasions and is proud of its role in the communities in which it serves. For more information visit www.vgmgroup.com. About Owlet, Inc. Owlet, Inc. (NYSE: OWLT), a leading pediatric health platform, is the only company in the world to offer U.S. FDA-cleared and internationally medically-certified wearable pediatric monitors, delivering hospital-grade technology directly in the home. Its award-winning pediatric products and innovative software combine clinically tested monitoring systems, an integrated video platform, and a simple, easy-to-use app, providing parents with real-time health insights to stay informed on their child's well-being, support restful sleep, and provide peace of mind anywhere. Since 2012, more than 2.5 million parents have trusted Owlet to monitor their children's well-being and sleep. This adoption has fueled one of the largest collections of pediatric health and sleep data in the world, powering innovations that bridge the critical gap between hospital and home. Owlet is driving a new standard in pediatric wellness by pairing advanced medical technology with consumer-friendly design. Its mission is simple yet ambitious: to give every baby and every family the best possible start in life. Learn more at www.owletcare.com and follow on LinkedIn and Instagram for company news and updates. Featured Blogs

Owlet, a New York-listed company, reported first-quarter results exceeding analyst expectations, with revenues of $23 million beating estimates by 8.4% and statutory losses of $0.12 per share coming in better than forecast. Following the results, five analysts have updated their forecasts for 2026, expecting revenues of $120.7 million, representing 13% growth from the past 12 months. This marks a slight reduction from previous estimates of $126.5 million. However, analysts now predict losses will narrow significantly to $0.35 per share, improving from earlier forecasts of $0.50 per share. The consensus price target remains unchanged at $13.75, with estimates ranging from $13.00 to $15.00. Analysts expect Owlet to achieve 17% annualised revenue growth through 2026, outpacing both its historical 4.7% growth and the industry average of 7.9%.

Owlet, a smart infant monitoring company, reported first quarter 2026 revenue of $22.5 million, up 6.4% from $21.1 million in the prior year period. The company achieved record quarterly subscription revenue of $2.7 million and gross margin of 54.5%, despite tariff impacts. However, Owlet posted a net loss of $3.3 million, compared to net income of $3.0 million in Q1 2025. Co-founder Kurt Workman has reassumed the CEO role to lead the company's evolution into a comprehensive paediatric health platform. The company now has over 115,000 paying subscribers and has launched Owlet OnCall, a paediatric telehealth service. Owlet updated its 2026 guidance, lowering revenue expectations to $118–122 million from $126–130 million, whilst raising adjusted EBITDA guidance to $7–9 million from $3–5 million.